Physician profile
Timothy Klepper
NPI 1255488433
$2,943.04
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $845 · 2020: $113 · 2021: $188 · 2022: $241 · 2023: $1,185 · 2024: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054 · Travel and Lodging: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.42 |
| Travel and Lodging | $501.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $809.36 | 2019-2021 | |
| Medtronic, INC. | $696.43 | 2023 | Venaseal |
| Boston Scientific Corporation | $502.28 | 2023-2024 | Varithena Administration Pack |
| Organogenesis INC. | $337.45 | 2024 | Puraply Am, Affinity |
| Olympus America INC. | $114.81 | 2021-2022 | |
| Redhill Biopharma INC. | $113.41 | 2021-2022 | |
| Kci USA, INC. | $98.41 | 2020-2021 | |
| Royal Biologics, INC. | $95.42 | 2022 | |
| Covidien LP | $53.60 | 2019-2020 | |
| Smith+Nephew, INC. | $33.93 | 2019 | |
| Hartmann USA, INC. | $22.62 | 2021 | |
| Cashflow Solutions, LLC | $19.83 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Venclose INC. | $19.49 | 2020 | |
| Davol INC. | $13.25 | 2019 | |
| Avanos Medical | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Klepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.